149 related articles for article (PubMed ID: 30552384)
1. Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells.
Marusiak AA; Prelowska MK; Mehlich D; Lazniewski M; Kaminska K; Gorczynski A; Korwat A; Sokolowska O; Kedzierska H; Golab J; Biernat W; Plewczynski D; Brognard J; Nowis D
Oncogene; 2019 Apr; 38(15):2860-2875. PubMed ID: 30552384
[TBL] [Abstract][Full Text] [Related]
2. MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance.
Mehlich D; Łomiak M; Sobiborowicz A; Mazan A; Dymerska D; Szewczyk ŁM; Mehlich A; Borowiec A; Prełowska MK; Gorczyński A; Jabłoński P; Iżycka-Świeszewska E; Nowis D; Marusiak AA
Cell Death Dis; 2021 Nov; 12(12):1111. PubMed ID: 34839359
[TBL] [Abstract][Full Text] [Related]
3. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
4. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
[TBL] [Abstract][Full Text] [Related]
7. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
8. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.
Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z
Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204
[TBL] [Abstract][Full Text] [Related]
9. miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1.
Shyamasundar S; Lim JP; Bay BH
Int J Oncol; 2016 Dec; 49(6):2629-2636. PubMed ID: 27840899
[TBL] [Abstract][Full Text] [Related]
10. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
Kim SH; Ezhilarasan R; Phillips E; Gallego-Perez D; Sparks A; Taylor D; Ladner K; Furuta T; Sabit H; Chhipa R; Cho JH; Mohyeldin A; Beck S; Kurozumi K; Kuroiwa T; Iwata R; Asai A; Kim J; Sulman EP; Cheng SY; Lee LJ; Nakada M; Guttridge D; DasGupta B; Goidts V; Bhat KP; Nakano I
Cancer Cell; 2016 Feb; 29(2):201-13. PubMed ID: 26859459
[TBL] [Abstract][Full Text] [Related]
11. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
[TBL] [Abstract][Full Text] [Related]
12. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
14. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
15. MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Tumour Biol; 2016 Apr; 37(4):4991-9. PubMed ID: 26537583
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
Chen LL; Zhang ZJ; Yi ZB; Li JJ
Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
[TBL] [Abstract][Full Text] [Related]
17. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ
Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127
[TBL] [Abstract][Full Text] [Related]
18. Comparative use of CRISPR and RNAi to modulate integrin α3β1 in triple negative breast cancer cells reveals that some pro-invasive/pro-metastatic α3β1 functions are independent of global regulation of the transcriptome.
Kenney J; Ndoye A; Lamar JM; DiPersio CM
PLoS One; 2021; 16(7):e0254714. PubMed ID: 34270616
[TBL] [Abstract][Full Text] [Related]
19. Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis.
Martini M; Russo M; Lamba S; Vitiello E; Crowley EH; Sassi F; Romanelli D; Frattini M; Marchetti A; Bardelli A
Cancer Res; 2013 Mar; 73(6):1912-21. PubMed ID: 23319808
[TBL] [Abstract][Full Text] [Related]
20. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
